Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Norgard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Alabama Medicine : Journal of the Medical Association of the State of Alabama|February 1, 1985
Colorectal health checkM J Norgard, B K Fisher
Oncology|January 1, 1975
Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinomaN J DiBella, R A Nelson, M J Norgard
American Journal of Obstetrics and Gynecology|May 15, 1982
Metastatic Sertoli-Leydig cell tumor of the ovary during pregnancy treated by BV-CAP chemotherapyG L Pride, W J Pollock, M J Norgard
Archives of Internal Medicine|August 1, 1979
Bone marrow necrosis and degenerationM J Norgard, J T Carpenter, M E Conrad
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Annals of Internal Medicine|December 1, 1982
Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapyM C Poon, J R Durant, M J Norgard, et al.
Annals of Internal Medicine|February 1, 1979
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU)J R Durant, M J Norgard, T M Murad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1993
Outbreak of Pseudomonas cepacia bacteremia in oncology patientsD A Pegues, L A Carson, R L Anderson, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapyR A Beveridge, J A Miller, A N Kales, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alabama Medicine : Journal of the Medical Association of the State of Alabama|February 1, 1985
Colorectal health checkM J Norgard, B K Fisher
Oncology|January 1, 1975
Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinomaN J DiBella, R A Nelson, M J Norgard
American Journal of Obstetrics and Gynecology|May 15, 1982
Metastatic Sertoli-Leydig cell tumor of the ovary during pregnancy treated by BV-CAP chemotherapyG L Pride, W J Pollock, M J Norgard
Archives of Internal Medicine|August 1, 1979
Bone marrow necrosis and degenerationM J Norgard, J T Carpenter, M E Conrad
Cancer|July 1, 1979
Unusual manifestations of non-Hodgkin's lymphomaA M Elisei, M J Norgard, J R Durant, et al.
Annals of Internal Medicine|December 1, 1982
Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapyM C Poon, J R Durant, M J Norgard, et al.
Annals of Internal Medicine|February 1, 1979
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU)J R Durant, M J Norgard, T M Murad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1993
Outbreak of Pseudomonas cepacia bacteremia in oncology patientsD A Pegues, L A Carson, R L Anderson, et al.
Cancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapyR A Beveridge, J A Miller, A N Kales, et al.
Pageof 1